Silibinin component for the treatment of hepatitis

The invention relates to a silibinin component for use in the treatment of hepatitis C in a patient who does not respond to ribavirin/interferon therapy.

Saved in:
Bibliographic Details
Main Authors Rovati, Lucio Claudio, D'Amato, Massimo Maria, Ferenci, Peter, Dr, Pohl, Ralf-Torsten, Dr, Mengs, Ulrich, Dr
Format Patent
LanguageEnglish
French
German
Published 24.01.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a silibinin component for use in the treatment of hepatitis C in a patient who does not respond to ribavirin/interferon therapy.
Bibliography:Application Number: EP20110005445